Quantitative Wide-Field Imaging Techniques for Fluorescence Guided Neurosurgery

Fluorescence guided surgery (FGS) has fueled the development of novel technologies aimed at maximizing the utility of fluorescence imaging to help clinicians diagnose and in certain cases treat diseases across a breadth of disciplines such as dermatology, gynecology, oncology, ophthalmology, and neu...

Full description

Bibliographic Details
Main Authors: Pablo A. Valdes, Parikshit Juvekar, Nathalie Y. R. Agar, Sylvain Gioux, Alexandra J. Golby
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fsurg.2019.00031/full
id doaj-2a51fdb3508a4c7594447369f66e57d5
record_format Article
spelling doaj-2a51fdb3508a4c7594447369f66e57d52020-11-25T02:52:26ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2019-06-01610.3389/fsurg.2019.00031452779Quantitative Wide-Field Imaging Techniques for Fluorescence Guided NeurosurgeryPablo A. Valdes0Parikshit Juvekar1Nathalie Y. R. Agar2Sylvain Gioux3Alexandra J. Golby4Department of Neurosurgery, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesDepartment of Neurosurgery, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesDepartment of Neurosurgery, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesICube Laboratory, University of Strasbourg, Télécom Physique Strasbourg, Alsace, FranceDepartment of Neurosurgery, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesFluorescence guided surgery (FGS) has fueled the development of novel technologies aimed at maximizing the utility of fluorescence imaging to help clinicians diagnose and in certain cases treat diseases across a breadth of disciplines such as dermatology, gynecology, oncology, ophthalmology, and neurosurgery. In neurosurgery, the goal of FGS technologies is to provide the neurosurgeon with additional information which can serve as a visual aid to better identify tumor tissue and associated margins. Yet, current clinical FGS technologies are qualitative in nature, limiting the ability to make accurate, reliable, and repeatable measurements. To this end, developments in fluorescence quantification are needed to overcome current limitations of FGS. Here we present an overview of the recent developments in quantitative fluorescence guidance technologies and conclude with the most recent developments aimed at wide-field quantitative fluorescence imaging approaches in neurosurgery.https://www.frontiersin.org/article/10.3389/fsurg.2019.00031/fullfluorescence-guided surgeryquantitative fluorescence imagingprotoporphyrin IXtissue optical propertiesbrain tumors
collection DOAJ
language English
format Article
sources DOAJ
author Pablo A. Valdes
Parikshit Juvekar
Nathalie Y. R. Agar
Sylvain Gioux
Alexandra J. Golby
spellingShingle Pablo A. Valdes
Parikshit Juvekar
Nathalie Y. R. Agar
Sylvain Gioux
Alexandra J. Golby
Quantitative Wide-Field Imaging Techniques for Fluorescence Guided Neurosurgery
Frontiers in Surgery
fluorescence-guided surgery
quantitative fluorescence imaging
protoporphyrin IX
tissue optical properties
brain tumors
author_facet Pablo A. Valdes
Parikshit Juvekar
Nathalie Y. R. Agar
Sylvain Gioux
Alexandra J. Golby
author_sort Pablo A. Valdes
title Quantitative Wide-Field Imaging Techniques for Fluorescence Guided Neurosurgery
title_short Quantitative Wide-Field Imaging Techniques for Fluorescence Guided Neurosurgery
title_full Quantitative Wide-Field Imaging Techniques for Fluorescence Guided Neurosurgery
title_fullStr Quantitative Wide-Field Imaging Techniques for Fluorescence Guided Neurosurgery
title_full_unstemmed Quantitative Wide-Field Imaging Techniques for Fluorescence Guided Neurosurgery
title_sort quantitative wide-field imaging techniques for fluorescence guided neurosurgery
publisher Frontiers Media S.A.
series Frontiers in Surgery
issn 2296-875X
publishDate 2019-06-01
description Fluorescence guided surgery (FGS) has fueled the development of novel technologies aimed at maximizing the utility of fluorescence imaging to help clinicians diagnose and in certain cases treat diseases across a breadth of disciplines such as dermatology, gynecology, oncology, ophthalmology, and neurosurgery. In neurosurgery, the goal of FGS technologies is to provide the neurosurgeon with additional information which can serve as a visual aid to better identify tumor tissue and associated margins. Yet, current clinical FGS technologies are qualitative in nature, limiting the ability to make accurate, reliable, and repeatable measurements. To this end, developments in fluorescence quantification are needed to overcome current limitations of FGS. Here we present an overview of the recent developments in quantitative fluorescence guidance technologies and conclude with the most recent developments aimed at wide-field quantitative fluorescence imaging approaches in neurosurgery.
topic fluorescence-guided surgery
quantitative fluorescence imaging
protoporphyrin IX
tissue optical properties
brain tumors
url https://www.frontiersin.org/article/10.3389/fsurg.2019.00031/full
work_keys_str_mv AT pabloavaldes quantitativewidefieldimagingtechniquesforfluorescenceguidedneurosurgery
AT parikshitjuvekar quantitativewidefieldimagingtechniquesforfluorescenceguidedneurosurgery
AT nathalieyragar quantitativewidefieldimagingtechniquesforfluorescenceguidedneurosurgery
AT sylvaingioux quantitativewidefieldimagingtechniquesforfluorescenceguidedneurosurgery
AT alexandrajgolby quantitativewidefieldimagingtechniquesforfluorescenceguidedneurosurgery
_version_ 1724730081115373568